📢We are thrilled lead the oversubscribed $15M Series A investment in Evidently, a pioneering AI platform transforming hospitals and large health systems by synthesizing fragmented medical data from disparate sources into actionable insights. 💪 We are deeply impressed by the exceptional founding team led by CEO Feng Niu and CPO Kalie Dove-Maguire, MD, whose track records and combined expertise in AI and healthcare make them uniquely equipped to tackle one of healthcare's most critical challenges. 🩺 Evidently’s platform has already delivered significant financial and efficiency gains at top US health systems, reducing administrative burdens while enhancing care quality. Feedback from early customers has been exceptionally positive, reinforcing the team’s mission to equip healthcare providers with advanced technology solutions. ✅ This funding will enable Evidently to meet the rapidly growing demand for its ‘EvidentlyOne’ product while advancing new solutions for population health and clinical research. As part of the investment, Gülsah Wilke, supported by Sarah Kreik, will take a seat on Evidently’s board, bringing her experience as COO of healthtech scaleup Ada Health. 🎉We’re excited to back Feng Niu, Kalie Dove-Maguire, MD, and the entire Evidently team as they embark on the next phase of their growth. DN is joined by Framework Venture Partners and Fellows Fund along with existing investors Clear Ventures. #VC #AI #HealthTech
Very happy to welcome Evidently AI to the DN Capital portfolio! 🚀🚀🚀
Thrilled to be a part of the journey!
Looking forward to working with you guys!
Congratulations Feng Niu Jaeho Shin Vera Xu
Congrats!
VC at DN Capital | INSEAD MBA
1moCongratulations to the entire Evidently team! Very excited for what’s to come